MR-PET fusion imaging in evaluating adnexal lesions: a preliminary study

[1]  A. Loft,et al.  Standardized FDG uptake as a prognostic variable and as a predictor of incomplete cytoreduction in primary advanced ovarian cancer , 2011, Acta oncologica.

[2]  潘凌亚,et al.  Ovarian Cancer , 2010, Cancer Treatment and Research.

[3]  P. Taourel,et al.  [MR Imaging of primary ovarian tumors with pathologic correlation]. , 2009, Journal de radiologie.

[4]  H. Perrochia,et al.  Corrélations anatomopathologiques : IRM des tumeurs ovariennes primitives , 2009 .

[5]  A. Godwin,et al.  Hereditary ovarian carcinoma: Heterogeneity, molecular genetics, pathology, and management , 2009, Molecular oncology.

[6]  Yiyan Liu.  Benign ovarian and endometrial uptake on FDG PET-CT: patterns and pitfalls , 2009, Annals of nuclear medicine.

[7]  L. Turnbull,et al.  The accurate staging of ovarian cancer using 3T magnetic resonance imaging – a realistic option , 2008, BJOG : an international journal of obstetrics and gynaecology.

[8]  Y. Nishiyama,et al.  Monitoring the neoadjuvant therapy response in gynecological cancer patients using FDG PET , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[9]  O. Schillaci,et al.  Solitary pulmonary nodules: morphological and metabolic characterisation by FDG-PET-MDCT , 2007, La radiologia medica.

[10]  K. Sugimura,et al.  Developing an MR imaging strategy for diagnosis of ovarian masses. , 2006, Radiographics : a review publication of the Radiological Society of North America, Inc.

[11]  Wolfgang A Weber,et al.  Prediction of response to neoadjuvant chemotherapy by sequential F-18-fluorodeoxyglucose positron emission tomography in patients with advanced-stage ovarian cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  D. Grisaru,et al.  THE DIAGNOSTIC ACCURACY OF 18F-FLUORODEOXY-GLUCOSE PET/CT IN PATIENTS WITH GYNECOLOGICAL MALIGNANCIES , 2004, International Journal of Gynecologic Cancer.

[13]  F Dehdashti,et al.  Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  O. Ishiko,et al.  The usefulness and limits of magnetic resonance imaging in the differential diagnosis of pelvic tumors. , 2001, Oncology reports.

[15]  M D Blaufox,et al.  PET imaging in oncology. , 2000, Seminars in nuclear medicine.

[16]  S. Orsulic,et al.  Ovarian Cancer , 1993, British Journal of Cancer.

[17]  H. Hricak,et al.  Ovarian lesions: detection and characterization with gadolinium-enhanced MR imaging at 1.5 T. , 1991, Radiology.

[18]  T. Yen,et al.  Positron emission tomography in gynecologic cancer. , 2006, Seminars in nuclear medicine.

[19]  H. Hricak,et al.  Complex adnexal masses: detection and characterization with MR imaging--multivariate analysis. , 2000, Radiology.

[20]  M. Schwaiger,et al.  [Metabolic characterization of ovarian tumors with positron-emission tomography and F-18 fluorodeoxyglucose]. , 1997, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[21]  F. Jänicke,et al.  Metabolische Charakterisierung von Ovarialtumoren mit der Positronen-Emissions-Tomographie und F-18-Fluordeoxyglukose , 1997 .